|
Medical Device News
PRESS RELEASE ARCHIVES FROM SEND2PRESS® NEWSWIRE
NOTICE: THIS IS ARCHIVAL CONTENT AND LIKELY OUT OF DATE.
Original editor for Send2Press: Christopher L. Simmons
Sleep Solutions Announces the Relocation of its Corporate Headquarters to Maryland
Move Improves Access to Strategic Business and Regulatory Assets
Annapolis, MD - April 29, 2004 /Send2Press Newswire/ -- Sleep Solutions, Inc.
(www.SleepSolutions.com), the innovative medical device and healthcare services company
focusing on direct-to-patient sleep apnea testing services has announced the relocation of
its corporate headquarters to the Annapolis, Maryland area from Palo Alto, California.
"Although the genesis of Sleep Solutions was in the heart of the technology-rich Silicon
Valley, we believe this move will allow us to become more efficient, more effective, and
better able to support our existing and future customer base," said Michael J. Thomas,
President and CEO of Sleep Solutions, Inc. "The proximity to insurance and biotechnology
companies and federal institutions provides an unparalleled opportunity for growth specific
to our market."
Maryland's unique concentration of strategic assets in the Washington-Baltimore metro area
includes a corridor of business, government and university research resources located within
an hour's drive of one another. This includes Johns Hopkins University, Georgetown
University, the University of Maryland, the Food and Drug Administration (FDA), National
Institutes of Health (NIH), Walter Reed Army Institute of Research, the Department of
Veteran's Affairs, Naval Medical Research Center, the U.S. Army Medical Research and
Materiel Command and the U.S. Department of Health and Human Services, all located in
Maryland.
Maryland has the most sleep studies per capita in the United States. 70% of all sleep
studies conducted in the U.S. occur in the Eastern half of the country. Many of Sleep
Solutions' strategic partners are located on the East Coast, and the Company is committed to
creating continued value for these partners.
"We continue to align ourselves with industry and government leaders so that we can deliver
our sleep apnea testing services more quickly, accurately, and cost effectively to patients,
physicians, and managed care organizations," added Thomas.
"Our new corporate headquarters provides an important base for the company to continue to
deliver innovation to the sleep medicine and healthcare industry," he concluded.
About Sleep Solutions Inc.
Sleep Solutions Inc. provides technology and services for at-home diagnosis, therapy and
care management of sleep-disordered breathing, particularly obstructive sleep apnea (OSA).
As prevalent as Diabetes and Asthma, with the vast majority of the public undiagnosed,
approximately 40 million Americans suffer from some form of sleep-disordered breathing.
The
privately held company provides physicians and their patients a clinically validated, cost-
effective, accurate and comfortable alternative to in-laboratory sleep studies at half the
cost. The company's NovaSom QSG™ at-home diagnostic system employs proprietary sound
analysis technology and is delivered directly to patients via an innovative operational
network called MediTrack™.
A wide array of physician and consumer OSA resources are
available through the company's website.
• Previous News from Sleep Solutions, Inc.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the organization mentioned and/or quoted in the story. The organization providing the news to Send2Press is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements and public companies should be thoroughly researched before considering material investment. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article.
USE OF THE ABOVE NEWS ARTICLE
News is Copr. © 2004 Neotrope/Send2Press. Reproduction of this news article in any form requires written authorization. You may freely link to this article, or republish the "news release" text version linked to above under "Journalist Tools" without restriction except websites must retain /Send2Press Newswire/ as the source. Sites which offer/sell PR services or newswire services may not reprint our content without express written permission.
|
